dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
Published 7 years ago • 624 plays • Length 0:40Download video MP4
Download video MP3
Similar videos
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
2:07
study results for nivolumab and pembrolizumab in head and neck cancer
-
0:59
dr. vokes on different settings in head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
0:57
dr. vokes on moving immunotherapy into frontline for head and neck cancer
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
1:08
dr. vokes on curative treatment approaches in head and neck cancer
-
0:42
dr. vokes on biomarker selection in head and neck cancer
-
1:11
dr. vokes on the treatment landscape of recurrent head and neck cancer
-
4:35
patient selection for nivolumab in hnscc
-
1:54
dr. vokes on pembrolizumab plus chemotherapy and radiation in lung cancer
-
1:40
dr. vokes discusses the administration of multimodality therapy for lung cancer
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
1:34
dr. ferris discusses nivolumab in head and neck cancer
-
2:13
nivolumab in hnscc
-
26:30
head and neck cancer treatment update: pembrolizumab, nivolumab and pd-l1 markers
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
5:01
patient selection for pembrolizumab in hnscc
-
0:40
dr. joshua m. bauml on pembrolizumab versus chemo in head and neck cancers